Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin

[1]  E. Steinhagen-Thiessen.  Comparative Efficacy and Tolerability of 5 and 10 mg Simvastatin and 10 mg Pravastatin in Moderate Primary Hypercholesterolemia , 1994 .

[2]  V. Ribeiro,et al.  Comparative Study of the Efficacy and Tolerability of Simvastatin and Pravastatin in Patients with Primary Hypercholesterolaemia , 1993 .

[3]  J. Frohlich,et al.  Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. , 1993, The Canadian journal of cardiology.

[4]  Lambrecht Lj,et al.  Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group. , 1993 .

[5]  P. Toutouzas,et al.  A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group. , 1993, The American journal of cardiology.

[6]  J. Daubresse.  Comparison of the Efficacy, Safety and Tolerability of Simvastatin and Pravastatin for Hypercholesterolemia , 1993 .

[7]  A. Gotto,et al.  Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants. , 1992, Clinical therapeutics.

[8]  D. Illingworth,et al.  Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia. , 1992, Atherosclerosis.

[9]  D. Matthews,et al.  Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. , 1992, BMJ.

[10]  Lawrence A Leiter,et al.  Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia. , 1992, Clinical therapeutics.

[11]  H. Pan,et al.  Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia. , 1991, Clinical therapeutics.

[12]  C. Shear,et al.  Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. , 1991, The American journal of medicine.

[13]  M. Eriksson,et al.  Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels , 1990, Journal of internal medicine.

[14]  R. Lees,et al.  Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. , 1987, Annals of internal medicine.

[15]  A. Stalenhoef,et al.  EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA , 1986, The Lancet.

[16]  D. Illingworth,et al.  Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia. , 1984, The Journal of clinical investigation.